Penalty Amount
$49,100,000
Attorney General William Tong announced settlements with Heritage Pharmaceuticals and Apotex totaling $49.1 million to resolve allegations of price-fixing conspiracies for generic prescription drugs. The companies agreed to cooperate in ongoing multistate litigation and implement internal reforms to ensure fair competition.
The settlements require Heritage Pharmaceuticals to pay $10 million and Apotex to pay $39.1 million. Both companies must cooperate with the ongoing multistate litigation and adopt internal reforms to comply with antitrust laws and prevent future violations.
In-house legal teams should review all vendor, distributor, and customer agreements—particularly those involving generic drug supply, distribution, and co-marketing—for clauses that could enable anti-competitive behavior. Focus on pricing terms, market allocation provisions, exclusivity arrangements, and any agreements with direct competitors. Specific clauses to scrutinize include antitrust compliance certifications, audit rights, termination triggers for legal violations, and cooperation obligations in investigations. Given the settlements, contracts may need amendments to include explicit prohibitions against price-fixing and market division, mandatory antitrust training, enhanced reporting requirements, and provisions allowing for independent compliance audits to align with the internal reforms agreed to by the settling parties.
Entity
Heritage Pharmaceuticals and Apotex
Industry
HealthcareOfficial Press Release
https://portal.ct.gov/ag/press-releases/2024-press-releases/attorney-general-tong-announces-updates-in-litigation-against-generic-drug-manufacturers
AG Jepsen Leads Coalition in New Expanded Complaint in Feder
https://portal.ct.gov/AG/Press-Releases-Archived/2017-Press-Releases/AG-Jepsen-Leads-Coalition-in-New-Expanded-Complaint-in-Federal-Generic-Drug-Antitrust-Lawsuit
GDMS Complaint 51019 FINAL REDACTED PUBLIC VERSIONpdf
https://portal.ct.gov/-/media/AG/Downloads/GDMS Complaint 51019 FINAL REDACTED PUBLIC VERSIONpdf
Connecticut Attorney General Enforcement Page
https://portal.ct.gov/AG/Privacy/Privacy-Resources
On May 11, 2026, Connecticut Attorney General William Tong led a bipartisan coalition of 21 attorneys general in submitting a comment letter to the U.S. Food and Drug Administration (FDA) urging the agency to abandon draft guidance that would ease approvals for flavored e-cigarette products. The coalition argues the guidance ignores evidence that flavored e-cigarettes disproportionately drive youth addiction and that FDA has failed to enforce existing authorization requirements for e-cigarette products. The letter references past tobacco and e-cigarette enforcement actions, including the 1998 tobacco master settlement agreement and the 2022 $438.5 million settlement with JUUL Labs.
Connecticut’s legislature passed House Bill 5312, creating new civil enforcement mechanisms for deepfake digital sexual assault, including unauthorized dissemination of synthetically created intimate images and AI-generated child pornography. The bill establishes a private right of action for victims and empowers the Connecticut Attorney General to pursue civil injunctions and penalties against abusers and platforms hosting illegal content. This builds on prior Connecticut laws criminalizing unauthorized intimate image dissemination.
Connecticut Attorney General William Tong praised final passage of House Bill 5312, which creates new civil enforcement mechanisms for deepfake digital sexual assault. The legislation allows the AG to pursue civil injunctions and penalties against platforms that disseminate illegal synthetic intimate images, including AI-generated child pornography, and establishes a private right of action for victims. The bill builds on prior Connecticut laws criminalizing unauthorized dissemination of intimate images.
$300K
Connecticut Attorney General William Tong announced a settlement with international trade platform Made-in-China to cease all U.S. sales of unlawful 'research grade' GLP-1 weight loss drugs following an investigation into direct sales to consumers without prescriptions or medical oversight. The settlement prohibits the platform from hosting GLP-1 sales to U.S. customers, requires a monitoring system to remove non-compliant listings, and imposes a $300,000 penalty suspended after an initial $30,000 payment. Additional settlements were announced with Radiance Medspa and Advanced Medical Weight Loss over compounded non-FDA approved GLP-1 drugs.
Connecticut Attorney General William Tong issued a statement on May 1, 2026, announcing the final passage of bipartisan legislation targeting youth social media addiction and artificial intelligence harms. The legislation imposes new obligations on social media companies regarding minor account settings, parental consent, and reporting, as well as requirements for AI chatbot operators and employers using automated decision tools. The statement also references ongoing enforcement actions against Meta and TikTok for allegedly designing addictive platform features for youth.
Connecticut Attorney General William Tong issued a statement on May 1, 2026, following final passage of bipartisan legislation to combat youth social media addiction and regulate artificial intelligence harms. The legislation imposes new requirements on social media companies regarding minor users, including parental consent for addictive algorithms, default privacy settings, and annual reporting obligations. It also establishes rules for AI chat bots and automated employment decision tools, including disclosure requirements and self-harm detection protocols.